Freenome
Curated by SignalProvider of a deep learning platform for detecting circulating cancer-related markers
Overview
Provider of a deep learning platform for detecting circulating cancer-related markers. It offers a platform for detecting circulating cancer-related markers in patient blood samples. Its proprietary technology uses deep learning to detect cell-free DNA, immune cell fragments, and metabolic markers in the blood. It allows physicians to classify tumor types and develop treatment therapies for prostate, breast, colorectal, and lung cancer.
Key facts
- Founded
- 2014
- Headquarters
- United States
- Stage
- Sign up to view
- Industry
- Life Sciences Technology
Business model
- 2 products and services
- Sign up to view
Contact
- Primary office
- Sign up to view
- Sign up to view
- Phone
- Sign up to view
Open roles
55 rolesInventory Specialist I (Contractor)
Brisbane, CA · On-site · Volunteer
Quality Control Specialist I (Contractor)
Brisbane, CA · On-site · Volunteer
Clinical Laboratory Associate I (Contractor)
Brisbane, CA · On-site · Volunteer